A carregar...
Current status of immunological approaches for the treatment of prostate cancer
PURPOSE OF REVIEW: The recent Food and Drug Administration approval of sipuleucel-T for metastatic castration-resistant prostate cancer and of the anticytotoxic T-lymphocyte antigen 4 antibody (Ipilimumab) for metastatic melanoma has led to a renewed interest in immunotherapy for prostate and other...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3444809/ https://ncbi.nlm.nih.gov/pubmed/22328018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOU.0b013e3283519ad5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|